Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

22%

4 trials in Phase 3/4

Results Transparency

36%

4 of 11 completed with results

Key Signals

4 with results92% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (5)
P 1 (4)
P 2 (2)
P 3 (4)

Trial Status

Completed11
Recruiting3
Enrolling By Invitation2
Not Yet Recruiting1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT05754190Recruiting

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

NCT04144972Not ApplicableRecruiting

Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain

NCT06155487Phase 1Enrolling By Invitation

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects

NCT06241820Not ApplicableCompleted

The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index

NCT06218784Phase 1RecruitingPrimary

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

NCT05496205Phase 1Completed

A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers

NCT06130514Not ApplicableNot Yet Recruiting

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block

NCT06410222Enrolling By InvitationPrimary

Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.

NCT03745404Phase 3CompletedPrimary

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

NCT03765697Phase 3CompletedPrimary

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

NCT03584061Not ApplicableCompletedPrimary

Treatment of Chronic Postherpetic Pain With Fat Grafting

NCT01270828Phase 3CompletedPrimary

Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia

NCT03974438Not ApplicableCompletedPrimary

Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.

NCT03447756Phase 1CompletedPrimary

Titration Study of ABX-1431

NCT01748877Phase 2CompletedPrimary

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

NCT01124097Phase 3TerminatedPrimary

Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia

NCT01426230CompletedPrimary

Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia

NCT00475904Phase 2CompletedPrimary

A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

Showing all 18 trials

Research Network

Activity Timeline